Malignant Extrahepatic Bile Duct Neoplasm

Malignant Extrahepatic Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–50 of 162 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05712356	A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors(BOLSTER)	completed	Phase 2	66	Lisata Therapeutics, Inc.INDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT02293954	Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer	active not recruiting	N/A	20	City of Hope Medical CenterOTHER	1	Sep 24, 2026